Home  /  Resource Library  /  Fixed duration or MRD guided venetoclax maintenance treatment in patients with CLL unfit for first-line FCR: Results from HOVON 139/GIVE trial

Fixed duration or MRD guided venetoclax maintenance treatment in patients with CLL unfit for first-line FCR: Results from HOVON 139/GIVE trial

EHA 2021